Zevra Therapeutics
ZVRA
#6931
Rank
A$0.88 B
Marketcap
A$14.95
Share price
2.98%
Change (1 day)
38.73%
Change (1 year)

Earnings for Zevra Therapeutics (ZVRA)

Earnings in 2025 (TTM): A$92.45 Million

According to Zevra Therapeutics's latest financial reports the company's current earnings are A$84.38 Million. In 2024 the company made an earning of -A$0.12 Billion a decrease over its 2023 earnings that were of -A$55.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Zevra Therapeutics from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$92.45 M-179.94%
2024 -A$0.12 Billion107.97%
2023 -A$55.62 Million-5.55%
2022 -A$58.88 Million418.02%
2021 -A$11.37 Million44.87%
2020 -A$7.85 Million-68.85%
2019 -A$25.19 Million-63.58%
2018 -A$69.16 Million37.16%
2017 -A$50.43 Million283.79%
2016 -A$13.14 Million-81.21%
2015 -A$69.94 Million130.03%
2014 -A$30.41 Million